Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ian Thomas Nisbet | M | 70 |
Velacor Therapeutics Pty Ltd.
 Velacor Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Velacor Therapeutics Pty Ltd. develops novel therapeutics for prostate cancers. The firm offers novel treatment for prostate, glioblastoma, ovarian and lung cancer. The company was founded by Christopher Hovens in 2005 and is headquartered in Parkville, Australia. | - |
| Ray Wilson | M | - |
Velacor Therapeutics Pty Ltd.
Velacor Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Velacor Therapeutics Pty Ltd. develops novel therapeutics for prostate cancers. The firm offers novel treatment for prostate, glioblastoma, ovarian and lung cancer. The company was founded by Christopher Hovens in 2005 and is headquartered in Parkville, Australia. | - |
| Vanessa Waddell | M | - |
Velacor Therapeutics Pty Ltd.
Velacor Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Velacor Therapeutics Pty Ltd. develops novel therapeutics for prostate cancers. The firm offers novel treatment for prostate, glioblastoma, ovarian and lung cancer. The company was founded by Christopher Hovens in 2005 and is headquartered in Parkville, Australia. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Corcoran Niall | M | - |
Velacor Therapeutics Pty Ltd.
Velacor Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Velacor Therapeutics Pty Ltd. develops novel therapeutics for prostate cancers. The firm offers novel treatment for prostate, glioblastoma, ovarian and lung cancer. The company was founded by Christopher Hovens in 2005 and is headquartered in Parkville, Australia. | - |
| Costello Anthony | M | - |
Velacor Therapeutics Pty Ltd.
Velacor Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Velacor Therapeutics Pty Ltd. develops novel therapeutics for prostate cancers. The firm offers novel treatment for prostate, glioblastoma, ovarian and lung cancer. The company was founded by Christopher Hovens in 2005 and is headquartered in Parkville, Australia. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Australia | 5 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Christopher Hovens
- Contatti personali
